Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
8.75
-0.95 (-9.79%)
May 6, 2025, 4:00 PM EDT - Market closed

Stoke Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-88.98-104.7-101.07-85.81-52.24
Upgrade
Depreciation & Amortization
2.182.471.550.970.89
Upgrade
Loss (Gain) From Sale of Assets
-0-0.030
Upgrade
Loss (Gain) From Sale of Investments
-1.64-0.33-0.210.14-
Upgrade
Stock-Based Compensation
27.4725.2622.8516.455.77
Upgrade
Other Operating Activities
2.272.261.991.261.04
Upgrade
Change in Accounts Payable
3.09-3.21-3.532.95.2
Upgrade
Change in Unearned Revenue
-29.39-3.3551.74--
Upgrade
Change in Other Net Operating Assets
-1.840.53-5.18-2.85-2.88
Upgrade
Operating Cash Flow
-86.85-81.07-31.87-66.91-42.22
Upgrade
Capital Expenditures
-0.2-1.62-3.96-1.2-1.05
Upgrade
Investment in Securities
-107.27107.56-41.92-75.23-
Upgrade
Investing Cash Flow
-107.48105.95-45.88-76.43-1.05
Upgrade
Issuance of Common Stock
131.0953.0146.411.29108.59
Upgrade
Other Financing Activities
--0-0-0.49
Upgrade
Financing Cash Flow
131.0953.0146.411.28108.11
Upgrade
Net Cash Flow
-63.2377.89-31.34-142.0564.84
Upgrade
Free Cash Flow
-87.05-82.68-35.83-68.11-43.27
Upgrade
Free Cash Flow Margin
-238.15%-941.72%-288.82%--
Upgrade
Free Cash Flow Per Share
-1.61-1.88-0.92-1.85-1.29
Upgrade
Levered Free Cash Flow
-26.45-45.07-36.15-34.78-24.35
Upgrade
Unlevered Free Cash Flow
-26.45-45.07-36.15-34.78-24.35
Upgrade
Change in Net Working Capital
-7.07-0.25-8.34-2.49-3.2
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q